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Abstract
To evaluate the results in metabolic control at newly discovered type 2 diabetic mellitus 
(T2Dm) patients regarding the lifestyle optimization only. In this short (1 year) observa-
tional study we included a number of 1855 newly discovered T2Dm patients. We com-
pared body mass index (bmI), fasting blood glucose (Fbg), hba1c, triglycerides (Tg), 
high density level cholesterol (hDlc) all these recorded initially at the diagnosis and 
then 1 year later. at baseline 52.91% males and 52.41% females were recommended 
only lifestyle   and the rest was treated with metformin, sulfonylurea or insulin. after 
one year the patients who remained on lifestyle only decreased with only 5%, dem-
onstrating that lifestyle optimisation remains one of the most important “therapeutic” 
tools in the metabolic control of T2Dm patients studied.
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introduction
Classically, lifestyle changes (diet and 
exercise) have been considered a cor-
nerstone of the treatment of both type 
1 and 2 diabetic patients. Recently, 
some guidelines (1) recommend that 
drug therapy must be initiated as soon 
as possible after the diagnosis of dia-
betes. Weight loss strategy in patients 
with type 2 diabetes mellitus (T2DM) 
consists in low caloric and low fat di-
ets. 
The aim of our study was to assess 
the safety and efficacy of one year life-
style intervention as the single first 
therapeutic step in newly diagnosed 
T2DM patients. 
patients and methods
This study was conducted in the out-
patient Diabetic Center  “Ion Pavel” 
belonging to the National Institute 
of Diabetes “N.C. Paulescu”, from 1st 
January – 31st December 2010. Dur-
ing this period 1855 newly diagnosed 
T2DM patients have been registered. 
After the exclusion of all primary 
insulin dependent patients (2) and 
gestational diabetes patients, there re-
mained: 909 males (49.91%) mean age 
56.32(±12.24) years, and 912 females 
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T2DM diagnosis and recommendations on diet and physical ex-
ercise have been done by the same team, in accordance with the 
current diabetes care standards in the Center. 
results and Discussion 
The main clinical and biochemical characteristics of the studied 
parameters recorded (for males and females) during the first year 
after the onset of diabetes are given in Table 1. The body mass 
index (BMI) was calculated as weight (kg)/height (m²). Fasting 
venous blood samples were taken to determine fasting blood 
glucose (FBG), total cholesterol, triglycerides (TG), high den-
sity level cholesterol (HDLc) and glycated hemoglobin (HbA1c). 
Comparison between women and men, in two visits was statisti-
cally analyzed using Epi info, with significance threshold set at 
p<0.05. The biochemical characteristics were presented as mean 
± standard deviation.
It can be seen the dynamics of HbA1c, FBG, TG, HDLc in the 
first year after the onset of diabetes. Median HbA1c was during 
the first visit for males 9.03% and during the second visit we 
observed a significant decrease at 7.6% and for females during 
the first visit was 8.43% also with a significant decrease at 7.64%. 
Median fasting glucose (mg/dl) at baseline was 215.65mg/dl for 
males with a decrease to 176.42mg/dl and for females at baseline 
was 204.84mg/dl with a decrease to 159.95 mg/dl.
As can be seen, the incidences of diabetes begin to increase 
from 25-30 years with a sharp slope between 50 and 60 years, 
with a maximum at 56-60 years. After 60 years, up to 80-90 
years the incidence slowly decreases. A small difference in 
incidence in females can be noted with a lower incidence in 
males before 60 years, becoming higher after that age. This 
corresponds with another epidemiologic study publish by our 
group in 1994 (3).
Lifestyle optimization only as therapy at baseline was recom-
mended in 52.41% of females and 52.91% of males. Oral agents 
were prescribed from the beginning due to higher values of 
HbA1c or to associated chronic complications or comorbidites 
to 231 males and 240 females. Only 26.31% of the females were 
taking metformin while 11.51% were taking sulfonylurea, and 
only 26.07% of the males were taking metformin while 11.55% 
were taking sulfonylurea. A short period of insulin treatment 
was recommended at baseline for 8.80% of the males and 9.75% 
of the females. The majority of these patients needed a rapid and 
good metabolic control before surgical intervention for various 
reasons.
After one year 38.83% of the males and 41.33% of the fe-
males remained only on lifestyle optimization and some others 
were transferred on oral agents - metformin for 35.64% of the 
males and 34.21% of the females; sulfonylurea for 15.51% of the 
males and 13.15% of the females.  Only 10.01% of the males and 
11.29% of the females were using insulin (Fig.3). This observa-
tion support our view that the lifestyle optimization is one of the 
most important and powerful “treatment” in T2DM patients.
Triglyceride:HDL cholesterol ratio (4) is one of the most use-
ful indicators of proatherogenic profile. The ratio is significantly 
higher in men then in women, explaining the lower frequencies 
of cardiovascular complications noticed for women. However, 
both in males and females this ratio increases with BMI, sug-
gesting that the lipids found in the circulatory are connected 
with the metabolic function of adipocytes and also with the liver 
function which often affected because higher amounts of fat in 
non-alcoholic fatty liver disease (5,6).
Conclusion
We recorded a significant decrease (p<0.01) in FBG, HbA1c, tri-
table 1. The clinical and biochemical characteristics for type 2 diabetic patients at baseline and one year later.
Male Female
First visit second visit First visit second visit
BMI (kg/m2) 29.73 ± 5.43 29.03 ± 4.86# 31.74 ± 6.67 31.18 ± 6.17#
FBG(mg/dl) 215.65± 98.65 171.42 ± 64.08* 204.84 ± 99.32 159.95±51.9**
HbA1c (%) 9.03± 3.71 7.6 ± 1.88* 8.43 ± 2.65 7.64 ± 1.52*
Triglycerides 245.29 ±268.82 176.68± 140.26*** 195.7 ± 179.34 153.66 ± 96.7***
HDL-c (mg/dl) 40.14± 11.5 41.36 ± 10.25* 45.25 ± 12.93 47.04 ± 12.65*
*p<0.001; **p<0.004; ***p<0.017; #ns
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Figure 1. age distribution of newly diagnosed type 2 diabetic 
patients.
Figure 2. The distribution of patients according to treatment 
recommendations at fi rst visit. 
Figure 3: The distribution of patients according to treatment 
after one year follow up. 
Figure 4. Triglycerides - hDl cholesterol ratio according to 
body mass index
glycerides, and increase in HDLc and no changes in BMI. Our 
data strongly support the “classical” view of lifestyle interven-
tion as the fi rst therapeutic step in T2DM. Th e introduction 
per primam of drug medication might diminish the interest 
and motivation of patients for the outstanding importance of 
lifestyle changes. Th e ratio TG/HDLc can therefore be a useful 
indicator of proatherogenic profi le. We recommend the imple-
mentation of lifestyle optimization even before drug administra-
tion for three reasons: (i) as we demonstrated, half of patients 
remain on medication one year aft er diagnosis, (ii) the idea must 
be ingrained in the patient’s mind that lifestyle optimization is 
an effi  cient form of treatment that must be respected for his/her 
entire life, and (iii) lifestyle optimization is much more cost ef-
fi cient (also see 7,8).
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